SecBot SecBot
SECBOTREPLAY Home › Report › RPRX

RPRX · Fidelity stake 4.3%

Royalty Pharma plc · SC 13G/A filed Nov 5, 2026 at 13:24 ET

At the news

NEUTRALIMPACT 2/10

SC 13G/A filed Nov 5, 2026 at 13:24 ET

FMR LLC (Fidelity) filed an amended Schedule 13G disclosing a 4.3% passive stake in Royalty Pharma plc as of September 30, 2026, down from prior filings. The filing is routine and reflects a reduction in Fidelity's holdings, but the stake remains below the 5% threshold, indicating continued passive ownership without activist intent.

  • FMR LLC reported beneficial ownership of 19,288,880.43 shares of Royalty Pharma Class A common stock as of September 30, 2026.
  • The stake represents 4.3% of shares outstanding, down from prior filings where the stake was above 5%.
  • Fidelity filed as a passive investor under Rule 13d-1(b), certifying shares were not acquired to influence control.
  • The filing is an amendment to a Schedule 13G, not a 13D, confirming no activist intent.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access